Stocks in the innovative drug concept continue to experience a rebound. On July 9, Jiuzhitang hit its daily limit, while Prasia surged by over 15%. Additionally, stocks such as Medicilon, Sinovac Biotech, and Hengrui Medicine also witnessed significant gains.